Search Results
Search for other papers by Hai-Yan Jia in
Google Scholar
PubMed
Search for other papers by Juan Chen in
Google Scholar
PubMed
Search for other papers by Zi-Xin Zhai in
Google Scholar
PubMed
Search for other papers by Wen-Wen Fan in
Google Scholar
PubMed
Search for other papers by Si-Jie Yuan in
Google Scholar
PubMed
Search for other papers by Qiong Liu in
Google Scholar
PubMed
Search for other papers by Xiao-Hui Yan in
Google Scholar
PubMed
Search for other papers by Qian-Qian Shen in
Google Scholar
PubMed
Search for other papers by Li-Ping Liu in
Google Scholar
PubMed
Introduction
Thyroid metastasis from clear cell renal cell carcinoma (ccRCC) is relatively rare, so ultrasound doctors lack experience with the disease, which can easily lead to misdiagnosis. We describe three cases of thyroid metastasis from ccRCC detected 12, 8, and 7 years after nephrectomy.
Case presentation
The first patient, a 78-year-old woman, was admitted to our institution for hoarseness and progressive dyspnea. Ultrasonography revealed bilateral thyroid nodules and abnormal cervical lymph nodes. Fine-needle aspiration biopsy (FNAB) and core needle biopsy (CNB) of the thyroid was nondiagnostic. The other two patients, a 54-year-old man and a 65-year-old man, were admitted to our institution for a goiter pressing on the trachea. In each case, ultrasonography revealed a partially cystic nodule of the left lobe of the thyroid gland. Histological examination of three patients after thyroidectomy showed thyroid metastasis from ccRCC.
Discussion/Conclusion
For patients with a history of ccRCC, long-term follow-up and routine thyroid ultrasonography should be performed. If a new thyroid nodule is found during the examination, metastases should be highly suspected. FNAB should be performed, even if benign ultrasound features seem to be in evidence. If the diagnosis of FNAB is incorrect and inconclusive, CNB should be performed.
Search for other papers by Genfeng Yu in
Google Scholar
PubMed
Search for other papers by Siyang Liu in
Google Scholar
PubMed
Search for other papers by Cheng Song in
Google Scholar
PubMed
Search for other papers by Qintao Ma in
Google Scholar
PubMed
Search for other papers by Xingying Chen in
Google Scholar
PubMed
Search for other papers by Yuqi Jiang in
Google Scholar
PubMed
Search for other papers by Hualin Duan in
Google Scholar
PubMed
Search for other papers by Yajun He in
Google Scholar
PubMed
Search for other papers by Dongmei Wang in
Google Scholar
PubMed
Search for other papers by Heng Wan in
Google Scholar
PubMed
Search for other papers by Jie Shen in
Google Scholar
PubMed
Background
This study aimed to examine the associations of thyroid hormone sensitivity indices, including free triiodothyronine-to-free thyroxine (FT3/FT4) ratio, thyroid feedback quantile-based index by FT4 (TFQIFT4), thyroid-stimulating hormone index (TSHI), and thyrotrophic thyroxine resistance index (TT4RI) with all-cause mortality in euthyroid adults.
Methods
The study included 6243 euthyroid adults from the National Health and Nutrition Examination Survey (NHANES) 2007–2012. FT3/FT4 ratio, TFQIFT4, TSHI, and TT4RI were calculated. The multivariable Cox proportional hazard regression, restricted cubic spline (RCS), and subgroup analysis were conducted.
Results
Individuals in fourth quartile (Q4) had lower all-cause mortality than those in first quartile (Q1) of FT3/FT4 ratio (hazard ratio (HR): 0.70, 95% CI: 0.51, 0.94). Regarding TFQIFT4, individuals in Q4 of TFQIFT4 had a 43% higher all-cause mortality than those in Q1 (HR: 1.43, 95% CI: 1.05, 1.96) (P < 0.05, all). Compared with participants in Q1, no associations of TSHI and TT4RI with mortality were found. TFQIFT4 was linearly and positively associated with mortality. However, the FT3/FT4 ratio showed a U-shaped association with mortality.
Conclusions
Increased risk for all-cause mortality was positively associated with TFQIFT4, suggesting that increased risk for all-cause mortality was associated with decreased central sensitivity to thyroid hormones. Furthermore, the FT3/FT4 ratio showed a U-shaped association with mortality, with an inflection point at 0.5. However, more cohort studies are needed to validate the conclusions.
